TGFB1 and neoplasm: In mice carrying s.c. H238 tumors treated s.c. with PSP alone for 11 days, tumor specimens had a slight decrease in TGF-β staining (compared with untreated controls), which was significantly augmented by IL-2 cotreatment (9).